Targeting acetylated high mobility group box 1 protein (HMGB1) and toll‐like receptor (TLR4) interaction to alleviate hypertension and neuroinflammation in fructose‐fed rats
This article is part of a themed issue Recent Innovations in Targeting Redox Biology for Therapeutics. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.1/issuetoc.
Authors
- Chiu‐Yi Ho (ORCID: https://orcid.org/0000-0002-8081-3946)
- Ching‐Jiunn Tseng (ORCID: https://orcid.org/0000-0002-5846-1817)
- Gwo‐Ching Sun
- Michael Hsiao (ORCID: https://orcid.org/0000-0001-8529-9213)
- Pei‐Wen Cheng (ORCID: https://orcid.org/0000-0002-5997-9247)
- Tzyy‐Yue Wong (ORCID: https://orcid.org/0000-0002-9616-651X)
- Yu‐Te Lin (ORCID: https://orcid.org/0000-0001-5107-5094)
Institutions
- National Sun Yat-sen University (TW)
- National Taiwan University (TW)
- China Medical University (TW)
- Genomics Research Center, Academia Sinica (TW)
- China Medical University Hospital (TW)
- Kaohsiung Veterans General Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1111/bph.17402
- Citations
- 5
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 1.91
Funders
- Ministry of Science and Technology, Taiwan
- Kaohsiung Veterans General Hospital
- National Science and Technology Council